Free tool
Diagnostics stocks
We cover 7 companies grouped under the Diagnostics theme. The median market value in the group is $7.02M. Across the group, the median move over the past trading day is −1.38%. Price change over the past year runs from −98.3% to −25.2% across the middle 80 percent of the group, with a median of −79.2%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
7 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| 0K3W.L | Myriad Genetics, Inc. | $3.15 | +2.95% | −49.12% | −46.71% |
| N3B.F | Anbio Biotechnology | 5.50 EUR | −36.78% | −67.46% | −86.59% |
| CIZ.L | Cizzle Biotechnology Holdings Plc | 1.50 GBP | −26.83% | −3.23% | +7.14% |
| VRCI.L | Verici Dx plc | 0.23 GBP | −35.71% | −68.97% | −57.14% |
| VNRX | VolitionRx Limited | $0.38 | −56.30% | −92.88% | −97.21% |
| ADTX | Aditxt, Inc. | $0.00 | −48.00% | −100.00% | −100.00% |
| 2CUREX.ST | 2cureX AB (publ) | 0.51 SEK | −71.95% | −5.02% | −79.23% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.